⌘K

Home/Filings/4/0001209191-13-029245

4//SEC Filing

Bartizal Ken 4

Accession 0001209191-13-029245

CIK 0001356857other

View on SEC.gov Company Profile

Filed

May 27, 8:00 PM ET

Accepted

May 28, 7:55 PM ET

Size

4.7 KB

Accession

0001209191-13-029245

Insider Transaction Report

Form 4

Period: 2013-05-24

Trius Therapeutics IncTSRX

Chief Development Officer

Transactions

Sale
Common Stock
2013-05-24$7.93/sh−12,000$95,119→ 98,927 total

Footnotes (1)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Trius Therapeutics Inc

CIK 0001356857

Entity typeother

Related Parties

1

filerCIK 0001478832

Filing Metadata

Form type: 4
Filed: May 27, 8:00 PM ET
Accepted: May 28, 7:55 PM ET
Size: 4.7 KB

View on SEC.gov